Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Top Cited Papers
- 12 September 2005
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (38) , 13604-13609
Abstract
Human pharmacokinetics data indicate that i.v. ascorbic acid (ascorbate) in pharmacologic concentrations could have an unanticipated role in cancer treatment. Our goals here were to test whether ascorbate killed cancer cells selectively, and if so, to determine mechanisms, using clinically relevant conditions. Cell death in 10 cancer and 4 normal cell types was measured by using 1-h exposures. Normal cells were unaffected by 20 mM ascorbate, whereas 5 cancer lines had EC 50 values of 50 of 0.5 mM) and suitability for addressing mechanisms. Extracellular but not intracellular ascorbate mediated cell death, which occurred by apoptosis and pyknosis/necrosis. Cell death was independent of metal chelators and absolutely dependent on H 2 O 2 formation. Cell death from H 2 O 2 added to cells was identical to that found when H 2 O 2 was generated by ascorbate treatment. H 2 O 2 generation was dependent on ascorbate concentration, incubation time, and the presence of 0.5-10% serum, and displayed a linear relationship with ascorbate radical formation. Although ascorbate addition to medium generated H 2 O 2 , ascorbate addition to blood generated no detectable H 2 O 2 and only trace detectable ascorbate radical. Taken together, these data indicate that ascorbate at concentrations achieved only by i.v. administration may be a pro-drug for formation of H 2 O 2 , and that blood can be a delivery system of the pro-drug to tissues. These findings give plausibility to i.v. ascorbic acid in cancer treatment, and have unexpected implications for treatment of infections where H 2 O 2 may be beneficial.Keywords
This publication has 59 references indexed in Scilit:
- Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance testDiabetic Medicine, 2004
- l-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanismsThe International Journal of Biochemistry & Cell Biology, 2004
- Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cellsHepatology, 2004
- Distinct Modes of Cell Death Induced by Different Reactive Oxygen SpeciesJournal of Biological Chemistry, 2002
- Hydrogen Peroxide in Human Urine: Implications for Antioxidant Defense and Redox RegulationBiochemical and Biophysical Research Communications, 1999
- Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agentMedical Hypotheses, 1995
- Direct detection of circulating free radicals in the rats using electron spin resonance spectrometryFree Radical Biology and Medicine, 1992
- Optimal EPR detection of weak nitroxide spin adduct and ascorbyl free radical signalsJournal of Biochemical and Biophysical Methods, 1992
- High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior ChemotherapyNew England Journal of Medicine, 1985
- Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced CancerNew England Journal of Medicine, 1979